Transcriptomic Analyses and Experimental Validation Identified Immune-Related lncRNA-mRNA Pair MIR210HG-BPIFC

Yuan Zhang1,2, Jiuxiao Zhao1, Qiao Jin1

  • 1Institute of Genetics and Reproduction, College of Animal Sciences, Zhejiang University, Hangzhou 310058, China.

Insights

Decreased expression of the MIR210HG-BPIFC long non-coding RNA pair is linked to hypertrophic cardiomyopathy (HCM) pathogenesis and immune cell infiltration in the heart.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Immunology

Background:

  • Hypertrophic cardiomyopathy (HCM) involves myocardial thickening and dysfunction.
  • Inflammatory responses are implicated in HCM pathogenesis.
  • The role of immune-related long non-coding RNAs (lncRNAs) in HCM is not well understood.

Purpose of the Study:

  • To comprehensively analyze immune-related lncRNAs in HCM.
  • To identify key lncRNAs and their regulatory networks in HCM.
  • To investigate the specific role of the MIR210HG-BPIFC lncRNA-mRNA pair in HCM.

Main Methods:

  • Reanalysis of transcriptomic RNA-Seq data from HCM patients and controls.
  • Weighted gene co-expression network analysis (WGCNA) to identify key modules.
  • Construction of a competing endogenous RNA (ceRNA) network.
  • Validation using an independent HCM dataset and an in vitro cell model.
  • Experimental validation of MIR210HG function and immune cell infiltration analysis.

Main Results:

  • A ceRNA network identified 9 lncRNAs and 17 mRNAs significantly correlated in HCM.
  • The MIR210HG-BPIFC lncRNA-mRNA pair was validated in an independent dataset and cell model.
  • Knockdown of MIR210HG affected miRNA and BPIFC mRNA expression in AC16 cells.
  • The MIR210HG-BPIFC pair is potentially involved in naïve CD4+ and CD8+ T cell infiltration.

Conclusions:

  • The decreased expression of the MIR210HG-BPIFC pair is significantly correlated with HCM pathogenesis.
  • This lncRNA-mRNA pair may play a role in immune cell infiltration in HCM.
  • MIR210HG-BPIFC represents a potential therapeutic target for HCM.